Eye (London, England)
Ocular adverse effects of bisphosphonates and association with osteonecrosis from a real-world database.
Samuel H Kim, Ehsan Rahimy, Euna B Koo, Chase A Ludwig, Andrea Lora Kossler, Prithvi Mruthyunjaya, Karen M Wai
Published: 202510.1038/s41433-025-04185-3
Abstract
OBJECTIVE: While bisphosphonates are widely used to treat osteoporosis, ocular adverse effects (OAEs) and their associations with serious systemic side effects, such as osteonecrosis, remain unexplored in large, diverse cohorts. METHOD: Retrospective…
Preview only. Read the full abstract at the source